Icecure Medical (ICCM)

Icecure Medical (ICCM) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.9M; returns 1 day +1.0%, 1 week -4.7%, 1 year -95.8%.

IceCure Medical is an Israel-based medical device company specializing in minimally invasive cryoablation technology for the destruction of tumors. Its flagship ProSense system utilizes liquid nitrogen (LN2) to freeze and destroy tumors in an outpatient setting, primarily targeting the breast, lung, kidney, and liver.

Groups ICCM belongs to

• Recent Reverse Splits
• Medical Devices
• Israel Companies
• Minimally Invasive Surgery
• Healthcare
• Healthcare Technology
• Israel
• Oncology
• Commercial Stage
• Medical Disposables
• Breast Cancer Treatment

ICCM financial model: income statement, cash flow and balance sheet